ADVFN ADVFN

Hot Features

Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Amarantus Bioscience Holdings Inc (EM)

Amarantus Bioscience Holdings Inc (EM) (AMBS)

0,000001
0,00
(0,00%)
Fermé 06 Juin 10:00PM

Amarantus Bioscience Holdings Inc (EM) (AMBS) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,000001
( - )
Prix Achat
0,00
Prix Vente
0,00
Volume échangé
24
0,00 Fourchette du Jour 0,00
0,000001 Plage de 52 semaines 0,25
Cap du marché
Clôture Veille
0,000001
Ouverture
-
Dernière Transaction
24
@
1.0E-6
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
US$ 1 409 780
Actions en circulation
630 407 411
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-0
Bénéfice par action (BPA)
-0,03
Chiffre d'affairess (LTM)
-
Bénéfice net (LTM)
-7,94M

À propos de Amarantus Bioscience Holdings Inc (EM)

Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company’s diagnostic products in development include the lymphocyte proli... Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company’s diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer’s disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple sclerosis. Its therapeutic products in development comprise Eltoprazine, a small molecule drug for the treatment of Parkinson’s disease Levadopa-Induced Dyskinesia and attention deficit hyperactivity disorders; and mesencephalic-astrocyte-derived neurotrophic factor for the treatment of various animal models, including retinitis pigmentosa and retinal artery occlusion. It also develops NuroPro, a neurodegenerative disease diagnostic platform with application in Parkinson’s disease; BC-SeraPro, an oncology diagnostic platform with application in breast cancer; and PhenoGuard platform for neurrotrophic factor discovery. In addition, the company develops Engineered Skin Substitute (ESS), a cell therapy-based autologous skin replacement product that is in mid-stage clinical development for the treatment of life-threatening severe burns. Amarantus BioScience Holdings, Inc. has a cooperative research and development agreement with the U.S. Army Institute of Surgical Research and Rutgers University. The company was formerly known as Amarantus Bioscience, Inc. and changed its name to Amarantus BioScience Holdings, Inc. in April 2013. Amarantus BioScience Holdings, Inc. was founded in 2008 and is headquartered in New York, New York. Show more

Secteur
Finance
Industrie
Asset Management Services
Siège social
New York, United States
Fondé
2026
Amarantus Bioscience Holdings Inc (EM) est coté dans le secteur Finance de la OTC Markets avec le ticker AMBS. Le dernier cours de clôture d'Amarantus Bioscience (EM) était de US$0,00. Au cours de la dernière année, les actions de Amarantus Bioscience (EM) ont été négociées dans une fourchette de prix de US$ 0,000001 à US$ 0,25.

Amarantus Bioscience (EM) compte actuellement 630 407 411 actions en circulation. La capitalisation boursière d'Amarantus Bioscience (EM) est de US$630,41 . Amarantus Bioscience (EM) a un ratio cours/bénéfice (ratio PE) de -0.00.

AMBS Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1001.0E-61.0E-61.0E-6505001.0E-6CS
4001.0E-61.0E-61.0E-6214671.0E-6CS
12001.0E-60.251.0E-611344904.84E-6CS
26001.0E-60.251.0E-66161374.79E-6CS
52001.0E-60.251.0E-64451671.259E-5CS
156-0.000999-99.90.0010.251.0E-66946980.00069737CS
260-0.007199-99.98611111110.00720.251.0E-616227100.00444929CS

AMBS - Frequently Asked Questions (FAQ)

What is the current Amarantus Bioscience Holdings Inc (EM) share price?
The current share price of Amarantus Bioscience Holdings Inc (EM) is US$ 0,000001
How many Amarantus Bioscience Holdings Inc (EM) shares are in issue?
Amarantus Bioscience Holdings Inc (EM) has 630 407 411 shares in issue
What is the market cap of Amarantus Bioscience Holdings Inc (EM)?
The market capitalisation of Amarantus Bioscience Holdings Inc (EM) is USD 630,41
What is the 1 year trading range for Amarantus Bioscience Holdings Inc (EM) share price?
Amarantus Bioscience Holdings Inc (EM) has traded in the range of US$ 0,000001 to US$ 0,25 during the past year
What is the PE ratio of Amarantus Bioscience Holdings Inc (EM)?
The price to earnings ratio of Amarantus Bioscience Holdings Inc (EM) is -0
What is the registered address of Amarantus Bioscience Holdings Inc (EM)?
The registered address for Amarantus Bioscience Holdings Inc (EM) is 45 Wall Street, New York, New York, 10005
What is the Amarantus Bioscience Holdings Inc (EM) website address?
The website address for Amarantus Bioscience Holdings Inc (EM) is www.amarantus.com
Which industry sector does Amarantus Bioscience Holdings Inc (EM) operate in?
Amarantus Bioscience Holdings Inc (EM) operates in the Asset Management Services sector

AMBS Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock